Home > Boards > US Listed > Medical - Drugs > Cocrystal Pharma Inc. (COCP)

New Dr. Frost investment announced just minutes ago

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
rtraster Member Profile
 
Followed By 6
Posts 245
Boards Moderated 0
Alias Born 09/05/13
160x600 placeholder
Cocrystal's stock jumps 25% after CDI-45205 shows encouraging antiviral activity against Delta, Gamma variants Seeking Alpha - 7/29/2021 8:23:18 AM
Cocrystal Pharma’s SARS-CoV-2 3CL Protease Lead CDI-45205 Demonstrates Broad-Spectrum Activity Against the SARS-CoV-2 Delta and Gamma Variants GlobeNewswire Inc. - 7/29/2021 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/20/2021 4:06:57 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/12/2021 8:01:26 AM
Cocrystal Pharma added to Russell Microcap Index Seeking Alpha - 6/28/2021 9:28:10 AM
Cocrystal Joins Russell Microcap® Index GlobeNewswire Inc. - 6/28/2021 8:00:00 AM
Cocrystal Pharma plans to initiate a phase 1 trial of CC-42344 in Q3 2021 Seeking Alpha - 6/23/2021 8:13:41 AM
Cocrystal Pharma Completes IND-enabling Studies with CC-42344 for the Treatment of Seasonal and Pandemic Influenza A, Plans t... GlobeNewswire Inc. - 6/23/2021 8:00:00 AM
Cocrystal’s soars 11% as CDI-45205 shows excellent antiviral activity against SARS-CoV-2 and variants Seeking Alpha - 6/14/2021 9:15:09 AM
Cocrystal’s Lead COVID-19 Antiviral CDI-45205 Shown to be Active Against SARS-CoV-2 and Two Prominent SARS-CoV-2 Variants GlobeNewswire Inc. - 6/14/2021 8:30:00 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 6/10/2021 6:01:10 AM
Cocrystal Pharma’s Participation in the Noble Capital Markets C-Suite Interview Series is Now Available Online GlobeNewswire Inc. - 6/9/2021 2:30:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/7/2021 8:31:12 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/1/2021 4:16:44 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/28/2021 8:10:58 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/28/2021 8:06:11 AM
Cocrystal Pharma Announces the Passing of Chairman, CEO and Co-founder Dr. Gary Wilcox GlobeNewswire Inc. - 5/28/2021 8:00:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 5/17/2021 5:14:32 PM
Cocrystal Pharma EPS in-line Seeking Alpha - 5/17/2021 8:33:16 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/17/2021 8:03:25 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 5/12/2021 2:15:49 PM
Cocrystal Pharma Announces Closing of $40 Million Bought Deal GlobeNewswire Inc. - 5/7/2021 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/6/2021 6:00:46 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/5/2021 5:03:53 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/5/2021 4:02:36 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences